|
|
||||||||
1From the Departments of Anatomy and Cell Biology and 2Ophthalmology, Wayne State University, Detroit, Michigan; 3Optometry and Vision Sciences, University of Melbourne, Victoria, Australia; and 4Department of Ophthalmology and Visual Sciences, Vanderbilt University, Nashville, Tennessee.
PURPOSE. To provide proof-of-concept that the extent of intraretinal manganese uptake after systemic MnCl2 injection, detected with manganese-enhanced MRI (MEMRI), assesses alterations in intraretinal ion demand in models of ocular insult.
METHODS. In Sprague–Dawley rats, retinal ion demand and thickness were measured from MEMRI data collected before, 4 hours after, or 1, 3, and 7 days after intraperitoneal injection of MnCl2. Choroidal contribution or blood-retinal barrier permeability surface area product (BRB PS') was determined using MRI after Gd-DTPA injection. Ocular injury was evaluated 24 hours after intravitreal injection of phosphate-buffered saline (PBS, vehicle) or PBS + ouabain, or after intraperitoneal injection of sodium iodate. Manganese retinal toxicity was assessed by comparing full-field, white-flash electroretinographic (ERG) data obtained before and after systemic MnCl2 administration. Rat choroidal thickness was measured from cross-sections prepared from paraformaldehyde-perfused adult rats.
RESULTS. Comparing pre– and post–Gd-DTPA images demonstrated minimal choroidal contribution to intraretinal analysis. Intraretinal signal intensity returned to baseline by 7 days after MnCl2 injection. After ouabain injection, receptor and postreceptor uptake of manganese were subnormal (P < 0.05). After sodium iodate exposure, intraretinal manganese uptake was supernormal (P < 0.05) and did not increase with increasing BRB PS'. ERG data did not show any effect of MnCl2 on photoreceptor a-wave and postreceptor b-wave relative to baseline at either observation time.
CONCLUSIONS. MEMRI measurements of uptake of systemically administered and nontoxic doses of manganese appear to be a powerful approach for measuring alteration in intraretinal ion demand in models of ocular injury.
This article has been cited by other articles:
![]() |
D. J. Calkins, P. J. Horner, R. Roberts, M. Gradianu, and B. A. Berkowitz Manganese-Enhanced MRI of the DBA/2J Mouse Model of Hereditary Glaucoma Invest. Ophthalmol. Vis. Sci., November 1, 2008; 49(11): 5083 - 5088. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Berkowitz, M. Gradianu, S. Schafer, Y. Jin, A. Porchia, R. Iezzi, and R. Roberts Ionic Dysregulatory Phenotyping of Pathologic Retinal Thinning with Manganese-Enhanced MRI Invest. Ophthalmol. Vis. Sci., July 1, 2008; 49(7): 3178 - 3184. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Berkowitz, R. Roberts, J. S. Penn, and M. Gradianu High-Resolution Manganese-Enhanced MRI of Experimental Retinopathy of Prematurity Invest. Ophthalmol. Vis. Sci., October 1, 2007; 48(10): 4733 - 4740. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Berkowitz, R. Roberts, A. Stemmler, H. Luan, and M. Gradianu Impaired Apparent Ion Demand in Experimental Diabetic Retinopathy: Correction by Lipoic Acid Invest. Ophthalmol. Vis. Sci., October 1, 2007; 48(10): 4753 - 4758. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |